| Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare P Mamoshina, L Ojomoko, Y Yanovich, A Ostrovski, A Botezatu, ... Oncotarget 9 (5), 5665, 2018 | 458 | 2018 |
| Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy R Ravi, KA Noonan, V Pham, R Bedi, A Zhavoronkov, IV Ozerov, ... Nature communications 9 (1), 741, 2018 | 289 | 2018 |
| Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors E Izumchenko, K Paz, D Ciznadija, I Sloma, A Katz, D Vasquez-Dunddel, ... Annals of Oncology 28 (10), 2595-2605, 2017 | 287 | 2017 |
| NEDD9 promotes oncogenic signaling in mammary tumor development E Izumchenko, MK Singh, OV Plotnikova, N Tikhmyanova, JL Little, ... Cancer research 69 (18), 7198-7206, 2009 | 152 | 2009 |
| Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA E Izumchenko, X Chang, M Brait, E Fertig, LT Kagohara, A Bedi, ... Nature communications 6 (1), 8258, 2015 | 151 | 2015 |
| The TGFβ–miR200–MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors E Izumchenko, X Chang, C Michailidi, L Kagohara, R Ravi, K Paz, M Brait, ... Cancer research 74 (14), 3995-4005, 2014 | 150 | 2014 |
| In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development IV Ozerov, KV Lezhnina, E Izumchenko, AV Artemov, S Medintsev, ... Nature communications 7 (1), 13427, 2016 | 137 | 2016 |
| Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia H Sharabani, E Izumchenko, Q Wang, R Kreinin, M Steiner, Z Barvish, ... International Journal of Cancer 118 (12), 3012-3021, 2006 | 105 | 2006 |
| Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization F Cortese, D Klokov, A Osipov, J Stefaniak, A Moskalev, J Schastnaya, ... Oncotarget 9 (18), 14692, 2018 | 94 | 2018 |
| Notch1 mutations are drivers of oral tumorigenesis E Izumchenko, K Sun, S Jones, M Brait, N Agrawal, W Koch, CL McCord, ... Cancer prevention research 8 (4), 277-286, 2015 | 89 | 2015 |
| SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells H Ozawa, RS Ranaweera, E Izumchenko, E Makarev, A Zhavoronkov, ... Clinical Cancer Research 23 (17), 5162-5175, 2017 | 68 | 2017 |
| Adenoid cystic carcinoma: emerging role of translocations and gene fusions PT Wysocki, E Izumchenko, J Meir, PK Ha, D Sidransky, M Brait Oncotarget 7 (40), 66239, 2016 | 68 | 2016 |
| Immune profiles in primary squamous cell carcinoma of the head and neck V Saloura, E Izumchenko, Z Zuo, R Bao, M Korzinkin, I Ozerov, ... Oral Oncology 96, 77-88, 2019 | 67 | 2019 |
| Patient‐derived xenografts as tools in pharmaceutical development E Izumchenko, J Meir, A Bedi, PT Wysocki, MO Hoque, D Sidransky Clinical Pharmacology & Therapeutics 99 (6), 612-621, 2016 | 67 | 2016 |
| Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use C Michailidi, M Hayashi, S Datta, T Sen, K Zenner, O Oladeru, M Brait, ... Cancer prevention research 8 (3), 208-221, 2015 | 60 | 2015 |
| Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks DZ Kelley, EL Flam, E Izumchenko, LV Danilova, HA Wulf, T Guo, ... Cancer research 77 (23), 6538-6550, 2017 | 58 | 2017 |
| Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? HS Nam, E Izumchenko, S Dasgupta, MO Hoque Biomarkers in medicine 11 (6), 475-489, 2017 | 56 | 2017 |
| Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status, and high-risk features EM Rettig, CH Chung, JA Bishop, JD Howard, R Sharma, RJ Li, ... Cancer prevention research 8 (4), 287-295, 2015 | 56 | 2015 |
| Common pathway signature in lung and liver fibrosis E Makarev, E Izumchenko, F Aihara, PT Wysocki, Q Zhu, A Buzdin, ... Cell Cycle 15 (13), 1667-1673, 2016 | 53 | 2016 |
| Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma A Zhavoronkov, E Izumchenko, RR Kanherkar, M Teka, C Cantor, ... Cell Cycle 15 (12), 1643-1652, 2016 | 53 | 2016 |
David SidranskyProfessor Johns Hopkins University在 jhmi.edu 的电子邮件经过验证
